The next stage in the pathway to medtech regulatory reform in Great Britain is expected in May, when the Medicines and Healthcare products Regulatory Agency (MHRA) will publish the government’s response to the late 2024 public consultation.
Medtech Regulatory System, IDAP And CERSI Top UK MHRA Agenda In March Update
Incoming MHRA Chair Gives Debt Of Thanks To Departing CEO June Raine
Britain’s medtech system progress, smarter ways of working at the agency and getting smarter AI and digital technologies into circulation for patients, were themes woven through the UK MHRA board’s 18 March meeting.
More from Regulation
More from Geography
• By
Medtech has not yet been spared from the Trump administration’s trade tariffs, which, for UK exporters will be 10% – half the rate applied to EU27 exporters.
• By
Medical devices, diagnostics, and equipment face tariffs announced by President Donald Trump, despite industry pleas for exemption. The tariffs, ranging from 10%-49%, impact most countries trading with the US, potentially hindering innovation and increasing costs in the medtech sector.
• By
The US FDA has published its final document to guide sponsors on using sex-specific data in designing clinical trials of medical devices. However, the guidance removes all references to gender that appeared in January’s draft guidance, released before the Trump administration took office.